RH director Mark Demilio disposed of 2,254 shares on January 14 in a transaction totaling $495,880. Following the sale, Demilio’s direct holding stands at 19,962 shares, down 10.15% from his prior position. The filing with the Securities and Exchange Commission confirms the sale and highlights insider sentiment as a key watch point for investors assessing management’s outlook on business performance.

In the quarter ended December 11, RH reported revenue of $883.81 million, representing an 8.9% year-over-year increase and essentially matching consensus estimates of $883.65 million. Net margin held at 3.22%, but earnings per share came in at $1.71, missing the consensus estimate of $2.13 by $0.42. Return on equity remained deeply negative at –161.72%, reflecting continued elevated leverage and margin pressures across the business.

Morgan Stanley raised its price objective to $275, signaling optimism on sustained revenue growth and potential multiple expansion. By contrast, Goldman Sachs lowered its target to $144 while maintaining a sell rating, citing margin risk and high financial leverage. Across 21 analysts tracked by MarketBeat, nine carry buy ratings, eight have holds and four assign sells, yielding a consensus target near $227 and underscoring mixed expectations for RH’s near-term valuation trajectory.

Hedge funds and institutional investors hold over 90% of RH’s shares. Durable Capital Partners increased its stake by 125.1% in Q2 to roughly 646,000 shares, while Westfield Capital initiated a position valued at approximately $67.6 million in Q3. Conversely, some funds have reduced exposure in recent quarters, reflecting divergent views on RH’s recovery timeline. This active rotation among large holders may amplify trading volatility as the company works to improve operating margins and deleverage its balance sheet.